View Publication On PubMed
Export The Gastrointestinal (GI) tract is composed of four main barriers: microbiological, chemical, physical and immunological. These barriers play important roles in maintaining GI tract homeostasis. In the crosstalk between these barriers, microbiota and related metabolites have been shown to influence GI tract barrier integrity, and alterations of the gut microbiome might lead to an increase in intestinal permeability. As a consequence, translocation of bacteria and their products into the circulatory system increases, reaching proximal and distal tissues, such as the liver. One of the most prevalent chronic liver diseases, Nonalcoholic Fatty Liver Disease (NAFLD), has been associated with an altered gut microbiota and barrier integrity. However, the causal link between them has not been fully elucidated yet. In this review, we aim to highlight relevant bacterial taxa and their related metabolites affecting the GI tract barriers in the context of NAFLD, discussing their implications in gut homeostasis and in disease.
SEEK ID: http://besttreat.hki-jena.de/publications/5
PubMed ID: 34280073
Projects: WP7 - Dissemination, Exploitation and Communication
Journal: Tissue Barriers
Citation: Tissue Barriers. 2021 Jul 19:1879719. doi: 10.1080/21688370.2021.1879719.
Date Published: 19th Jul 2021
Authors: M. V. Fernandez-Cantos, Johnson Lok, Valeria Iannone, H. El-Nezami, M. Kolehmainen, O. P. Kuipers
CreatorViews: 93
Created: 2nd Sep 2021 at 08:30
AttributionsNone
Download